First Time Loading...

Y-mAbs Therapeutics Inc
NASDAQ:YMAB

Watchlist Manager
Y-mAbs Therapeutics Inc Logo
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Watchlist
Price: 12.87 USD -5.44% Market Closed
Updated: May 10, 2024

Y-mAbs Therapeutics Inc
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Y-mAbs Therapeutics Inc
Tax Provision Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Tax Provision
-$561k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Tax Provision
-$1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Gilead Sciences Inc
NASDAQ:GILD
Tax Provision
-$617m
CAGR 3-Years
28%
CAGR 5-Years
23%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Tax Provision
-$582m
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Tax Provision
-$760.2m
CAGR 3-Years
-23%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Tax Provision
-$184.2m
CAGR 3-Years
22%
CAGR 5-Years
-4%
CAGR 10-Years
6%

See Also

What is Y-mAbs Therapeutics Inc's Tax Provision?
Tax Provision
-561k USD

Based on the financial report for Dec 31, 2023, Y-mAbs Therapeutics Inc's Tax Provision amounts to -561k USD.